Merck & Co. and Schering-Plough Corp. suspended television ads Tuesday for the cholesterol pills Vytorin and Zetia after a study questioned the benefit of the medicines. The Vytorin commercials were ...
WASHINGTON (Reuters) - A U.S. congressional panel will examine television commercials for cholesterol drugs Lipitor and Vytorin and for anemia drug Procrit at a Thursday hearing on whether such ...
For Immediate Release WHITEHOUSE STATION and KENILWORTH, N.J., Oct. 28, 2004 -- Results from a new clinical trial conducted in 1,902 patients with high cholesterol showed that VYTORIN TM ...
This article was originally on a blog post platform and may be missing photos, graphics or links. See About archive blog posts. Vytorin, the combination drug prescribed to lower cholesterol, sustained ...
WHITEHOUSE STATION and KENILWORTH, N.J., July 23, 2004 — Merck/Schering-Plough Pharmaceuticals announced today that the U.S. Food and Drug Administration has approved VYTORIN TM (ezetimibe/simvastatin ...
CHICAGO (Reuters) - Shortly after news reports saying the popular cholesterol drug Vytorin had missed the mark in a long-awaited study, calls and e-mails started pouring in to doctors in the United ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback